BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 35691540)

  • 1. Redoxisome and diabetic retinopathy: Pathophysiology and therapeutic interventions.
    Sharma I; Yadav KS; Mugale MN
    Pharmacol Res; 2022 Aug; 182():106292. PubMed ID: 35691540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thioredoxin/Txnip: redoxisome, as a redox switch for the pathogenesis of diseases.
    Yoshihara E; Masaki S; Matsuo Y; Chen Z; Tian H; Yodoi J
    Front Immunol; 2014 Jan; 4():514. PubMed ID: 24409188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redoxisome Update: TRX and TXNIP/TBP2-Dependent Regulation of NLRP-1/NLRP-3 Inflammasome.
    Yoshihara E; Matsuo Y; Masaki S; Chen Z; Tian H; Masutani H; Yamauchi A; Hirota K; Yodoi J
    Antioxid Redox Signal; 2024 Apr; 40(10-12):595-597. PubMed ID: 38386512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline.
    Chen W; Zhao M; Zhao S; Lu Q; Ni L; Zou C; Lu L; Xu X; Guan H; Zheng Z; Qiu Q
    Inflamm Res; 2017 Feb; 66(2):157-166. PubMed ID: 27785530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dl-3-n-Butylphthalide Inhibits NLRP3 Inflammasome and Mitigates Alzheimer's-Like Pathology via Nrf2-TXNIP-TrX Axis.
    Wang CY; Xu Y; Wang X; Guo C; Wang T; Wang ZY
    Antioxid Redox Signal; 2019 Apr; 30(11):1411-1431. PubMed ID: 29634349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memantine mitigates ROS/TXNIP/NLRP3 signaling and protects against mouse diabetic retinopathy: Histopathologic, ultrastructural and bioinformatic studies.
    ElSayed MH; Elbayoumi KS; Eladl MA; Mohamed AAK; Hegazy A; El-Sherbeeny NA; Attia MA; Hisham FA; Saleh MAK; Elaskary A; Morsi K; Mustsafa AMA; Enan ET; Zaitone SA
    Biomed Pharmacother; 2023 Jul; 163():114772. PubMed ID: 37116352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prodrug of epigallocatechin-3-gallate alleviates high glucose-induced pro-angiogenic factor production by inhibiting the ROS/TXNIP/NLRP3 inflammasome axis in retinal Müller cells.
    Du J; Wang Y; Tu Y; Guo Y; Sun X; Xu X; Liu X; Wang L; Qin X; Zhu M; Song E
    Exp Eye Res; 2020 Jul; 196():108065. PubMed ID: 32407725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking CHOP-dependent TXNIP shuttling to mitochondria attenuates albuminuria and mitigates kidney injury in nephrotic syndrome.
    Park SJ; Kim Y; Li C; Suh J; Sivapackiam J; Goncalves TM; Jarad G; Zhao G; Urano F; Sharma V; Chen YM
    Proc Natl Acad Sci U S A; 2022 Aug; 119(35):e2116505119. PubMed ID: 35994650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D
    Lu L; Lu Q; Chen W; Li J; Li C; Zheng Z
    J Diabetes Res; 2018; 2018():8193523. PubMed ID: 29682582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nrf2 inhibits NLRP3 inflammasome activation through regulating Trx1/TXNIP complex in cerebral ischemia reperfusion injury.
    Hou Y; Wang Y; He Q; Li L; Xie H; Zhao Y; Zhao J
    Behav Brain Res; 2018 Jan; 336():32-39. PubMed ID: 28851669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TXNIP: A key protein in the cellular stress response pathway and a potential therapeutic target.
    Choi EH; Park SJ
    Exp Mol Med; 2023 Jul; 55(7):1348-1356. PubMed ID: 37394581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial cells senescence is associated with NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome activation via reactive oxygen species (ROS)/thioredoxin-interacting protein (TXNIP) pathway.
    Yin Y; Zhou Z; Liu W; Chang Q; Sun G; Dai Y
    Int J Biochem Cell Biol; 2017 Mar; 84():22-34. PubMed ID: 28064010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis.
    Han Y; Xu X; Tang C; Gao P; Chen X; Xiong X; Yang M; Yang S; Zhu X; Yuan S; Liu F; Xiao L; Kanwar YS; Sun L
    Redox Biol; 2018 Jun; 16():32-46. PubMed ID: 29475133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.
    Liu Q; Zhang F; Zhang X; Cheng R; Ma JX; Yi J; Li J
    Mol Cell Biochem; 2018 Aug; 445(1-2):105-115. PubMed ID: 29264825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of the NLRP3 Inflammasome in Diabetic Retinopathy and Potential Therapeutic Targets.
    Raman KS; Matsubara JA
    Ocul Immunol Inflamm; 2022 Feb; 30(2):470-478. PubMed ID: 33026924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation of TXNIP-mediated oxidative stress and NLRP3 inflammasome activation contributes to SAHH inhibition-aggravated diabetic nephropathy.
    Dai X; Liao R; Liu C; Liu S; Huang H; Liu J; Jin T; Guo H; Zheng Z; Xia M; Ling W; Xiao Y
    Redox Biol; 2021 Sep; 45():102033. PubMed ID: 34119876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PKC Delta Activation Promotes Endoplasmic Reticulum Stress (ERS) and NLR Family Pyrin Domain-Containing 3 (NLRP3) Inflammasome Activation Subsequent to Asynuclein-Induced Microglial Activation: Involvement of Thioredoxin-Interacting Protein (TXNIP)/Thioredoxin (Trx) Redoxisome Pathway.
    Samidurai M; Palanisamy BN; Bargues-Carot A; Hepker M; Kondru N; Manne S; Zenitsky G; Jin H; Anantharam V; Kanthasamy AG; Kanthasamy A
    Front Aging Neurosci; 2021; 13():661505. PubMed ID: 34276337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mROS-TXNIP axis activates NLRP3 inflammasome to mediate renal injury during ischemic AKI.
    Wen Y; Liu YR; Tang TT; Pan MM; Xu SC; Ma KL; Lv LL; Liu H; Liu BC
    Int J Biochem Cell Biol; 2018 May; 98():43-53. PubMed ID: 29477360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Galectins and the P2X7 Purinergic Receptor as a Therapeutic Approach in the Neurovascular Inflammation of Diabetic Retinopathy.
    Lepre CC; Russo M; Trotta MC; Petrillo F; D'Agostino FA; Gaudino G; D'Amico G; Campitiello MR; Crisci E; Nicoletti M; Gesualdo C; Simonelli F; D'Amico M; Hermenean A; Rossi S
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-Regulation Thioredoxin Inhibits Advanced Glycation End Products-Induced Neurodegeneration.
    Ren X; Wang NN; Qi H; Qiu YY; Zhang CH; Brown E; Kong H; Kong L
    Cell Physiol Biochem; 2018; 50(5):1673-1686. PubMed ID: 30384364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.